On Tuesday, Shares of Medivation, Inc. (NASDAQ:MDVN), loss -3.27% to $120.85.
Medivation, declared that two abstracts detailing clinical data from studies of enzalutamide will be presented at the 2015 annual meeting of the American Urological Association (AUA) on May 17, 2015, in New Orleans.
The following abstracts will be presented during a late-breaking plenary session:
TERRAIN Trial: Prostate-specific Antigen Kinetics and Quality of Life Results of Enzalutamide as compared to Bicalutamide in Metastatic Castration-resistant Prostate Cancer
Arnauld Villers, M.D., Ph.D, professor of urology and chairman, Department of Urology, University of Lille, France
- Session Date/Time: Sunday, May 17, 11:06am - 11:13am CDT
- Location: NOMCC: Hall B1
Medivation, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat serious diseases in the United States. It offers XTANDI for the treatment of post-chemotherapy metastatic castration-resistant prostate cancer (mCRPC) patients.
Shares of Zillow Group, Inc. (NASDAQ:Z), declined -3.26% to $92.84, during its last trading session.
Zillow Group, which houses a portfolio of the largest and most vibrant rental, real estate and home-related brands on mobile and Web, added more multifamily partners to the Zillow® Rental Network in the past year than ever before, increasing new partnerships 84 percent year-over-year, from Q1 2014 to Q1 2015.
Many of the largest property administration companies in the country are already leveraging the Zillow Rental Network as part of their marketing strategies; nearly 90 percent of the National Multifamily Housing Council 50 Largest Apartment Managers count themselves as Zillow Rental Network customers.
Zillow Group closed its acquisition of Trulia in February. Within a few weeks, the rentals businesses were completely integrated, with the sales team working cohesively together on behalf of multifamily partners. Now, rental shoppers who visit Trulia or Trulia’s mobile apps have access to hundreds of thousands of rental listings powered by the Zillow Rental Network.
Zillow Group, Inc. operates real estate and home-related information marketplaces on mobile and the Web in the United States. It offers a portfolio of brands and products to assist people find vital information about homes, and connect with local professionals.
At the end of Tuesday’s trade, Shares of SUPERVALU Inc. (NYSE:SVU), dipped -3.25% to $8.64.
SUPERVALU, stated fourth quarter fiscal 2015 net sales of $4.36 billion and net earnings from ongoing operations of $36 million ($0.13 per diluted share).
Results for the fourth quarter of fiscal 2015 comprised of $30 million in after-tax debt refinancing, benefit plan and store closure costs and charges. When adjusted for these items, fourth quarter fiscal 2015 net earnings from ongoing operations were $66 million ($0.24 per diluted share) which comprised of an approximate $0.03 per diluted share benefit related to the additional week in fiscal 2015. Net earnings from ongoing operations for last year’s fourth quarter were $42 million ($0.15 per diluted share) and comprised of $8 million in after-tax net costs and charges primarily for employee severance and debt refinancing activities. When adjusted for these items, fourth quarter fiscal 2014 net earnings from ongoing operations were $50 million ($0.18 per diluted share).
“We finished the year with a strong quarter, highlighted by positive identical store sales at both Save-A-Lot and Retail Food in addition to the transition of the first stores in our important new relationship with Haggen,” said President and CEO Sam Duncan. “Overall, fiscal 2015 was a year of planned investment in all three of our business segments and I’m happy with how these investments have positioned us for growth in fiscal 2016.”
SUPERVALU INC., together with its auxiliaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Independent Business, Save-A-Lot, and Retail Food.
Finally, Tenet Healthcare Corp. (NYSE:THC), ended its last trade with -3.23% loss, and closed at $47.89.
Tenet Healthcare Corporation, stated Adjusted EBITDA of $529 million for the first quarter of 2015, an enhance of $142 million, or 37 percent, contrast to $387 million in the first quarter of 2014.
Tenet recorded $6 million in electronic health records incentives in the first quarter of 2015, a $3 million decrease contrast to $9 million in the first quarter of 2014. Electronic health record incentive payments are recorded based on the timing of when the company’s hospitals achieve meaningful use criteria.
Net operating revenues, after provision for doubtful accounts, grew by $502 million, or 12.8 percent, to $4.428 billion, contrast to net operating revenues of $3.926 billion in the first quarter of 2014. The majority of the company’s revenue growth was driven by a 5.9 percent enhance in same-hospital adjusted patient admissions, a 2.7 percent enhance in same-hospital net patient revenue per adjusted patient admission, and a $37 million enhance in revenue at Conifer from non-Tenet hospitals, representing a growth rate of 25.5 percent. The year-over-year comparison also benefitted from outpatient development activity, the acquisition of two hospitals and opening of one newly constructed hospital.
Selected operating expenses, defined as the sum of salaries, wages and benefits, supplies and other operating expenses, raised by 1.5 percent per adjusted admission in the quarter.
Tenet Healthcare Corporation, a healthcare services company, primarily operates acute care hospitals and related healthcare facilities in the United States. It operates through two segments, Hospital Operations and Other, and Conifer. The company’s general hospitals offer acute care services, operating and recovery rooms, radiology services, respiratory therapy services, clinical laboratories, and pharmacies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
